GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Additional Paid-In Capital

Akeso (AKESF) Additional Paid-In Capital : $1,017.7 Mil(As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Akeso Additional Paid-In Capital?


Akeso's quarterly additional paid-in capital increased from Dec. 2023 ($642.2 Mil) to Jun. 2024 ($778.3 Mil) and increased from Jun. 2024 ($778.3 Mil) to Dec. 2024 ($1,017.7 Mil).

Akeso's annual additional paid-in capital declined from Dec. 2022 ($657.7 Mil) to Dec. 2023 ($642.2 Mil) but then increased from Dec. 2023 ($642.2 Mil) to Dec. 2024 ($1,017.7 Mil).

Akeso Additional Paid-In Capital Historical Data

The historical data trend for Akeso's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso Additional Paid-In Capital Chart

Akeso Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial 402.43 629.12 657.71 642.19 1,017.70

Akeso Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 657.71 - 642.19 778.29 1,017.70

Akeso Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Akeso Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Akeso's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Akeso Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Additional Paid-In Capital
Comparable Companies
HKSE:01177 HKSE:06990 HKSE:01801 HKSE:02269 HKSE:01530 HKSE:09995 HKSE:01877 HKSE:01548 HKSE:02696 HKSE:09969 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
09926:Hong Kong 4RY:Germany
Address
6 Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437
Website
https://www.akesobio.com
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in USA.